细胞因子受体协会的几何调节调节合成激动体信号传递
Marc Expòsit1,2,3, Mohamad Abedi1,2, Aditya Krishnakumar1,2
1Department of Biochemistry, University of Washington, Seattle, WA, USA.
bioRxiv : the preprint server for biology
|November 24, 2025
概括
研究人员开发了一个新的蛋白质设计平台来控制细胞因子受体几何. 这允许精确调整免疫细胞信号通路和功能结果,从而实现可编程的免疫调制.
科学领域:
- 免疫学 免疫学 免疫学
- 蛋白质工程是指蛋白质工程.
- 系统生物学 系统生物学
背景情况:
- 细胞因子通过组装受体子单元来调解细胞通信.
- 受体几何学在细胞因子信号传递中的确切作用由于固定的自然连接体组合而不明.
- 了解这种几何结构对于破译和控制免疫反应至关重要.
研究的目的:
- 开发一个新的蛋白质设计平台,精确控制细胞因子受体几何.
- 研究不同的受体几何如何影响下游信号通路 (pSTAT) 和细胞功能.
- 通过对细胞因子信号的几何控制来探索可编程免疫调节的潜力.
主要方法:
- 设计了一个新型蛋白质设计平台,以将受体结合域硬化地架构成定义的空间安排.
- 将平台应用于各种细胞因子受体系统,包括IL-7,I/III型干扰素,IL-10,gp130和β常见.
- 分析了受体几何结构改变对pSTAT通路激活和特定细胞功能的影响,如抗原呈现,检查点诱导和细胞因子分泌.
主要成果:
- 证明不同的受体几何学可以偏向pSTAT途径的使用和调整功能结果.
- 成功分离特定的信号输出,例如将IL-7的pSTAT1与pSTAT5分开.
- 实现了功能选择性调制,比如在I型干扰素中将抗原呈现 (MHC-I) 与检查点诱导 (PD-L1) 分开,并微调IL-10活性.
- 创建了IL-6和IL-3的最小激动剂,并增强了合成受体配对.
结论:
- 受体几何是细胞因子活性和信号特异性的关键决定因素.
- 开发的蛋白质设计平台为剖析细胞因子机制提供了强大的工具.
- 这个平台可以创建具有可编程功能的新型免疫调节剂.
更多相关视频
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
9.0K
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
13.4K
相关概念视频
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
The Two-State Receptor Model
3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.0K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Receptor Downregulation in MVBs
2.7K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.7K
Amplifying Signals via Enzymatic Cascade
17.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.0K
Assembly of Signaling Complexes
6.4K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.4K
